| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |